New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
07:07 EDTLXRXLexicon and JDRF collaborate for Phase 2 trial of LX4211 in Type 1 diabetes
Lexicon announced that JDRF, the world's largest non-profit supporter of type 1 diabetes research, will provide funding to support a Phase 2, randomized, double-masked, placebo-controlled clinical trial to evaluate the efficacy and safety of LX4211 in a younger population with T1D. The primary objective of this study is to demonstrate the superiority of LX4211 versus placebo as adjunct to insulin treatment on HbA1c reduction at 12 weeks as well as several secondary endpoints, including reduced variability in blood glucose levels and lower insulin needs.
News For LXRX From The Last 14 Days
Check below for free stories on LXRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 12, 2014
09:14 EDTLXRXOn The Fly: Pre-market Movers
Subscribe for More Information
September 11, 2014
18:35 EDTLXRXOn The Fly: After Hours Movers
Subscribe for More Information
16:33 EDTLXRXLexicon publication of Phase 2b study shows LX4211 provides meaningful benefit
Subscribe for More Information
September 10, 2014
11:06 EDTLXRXLexicon management to meet with Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use